Comparative evaluation of anti-HER2 affibody molecules labeled with 68Ga and 111In using maleimido derivatives of DOTA and NODAGA.

被引:0
|
作者
Altai, M. [1 ]
Strand, J. [1 ]
Rosik, D. [2 ]
Selvaraju, R. [1 ]
Karlstrom, A. Eriksson [2 ]
Orlova, A. [1 ]
Tolmachev, V. [1 ]
机构
[1] Uppsala Univ, Uppsala, Sweden
[2] Royal Inst Technol KTH, Stockholm, Sweden
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP711
引用
收藏
页码:S299 / S299
页数:1
相关论文
共 26 条
  • [21] Selection Of The Optimal Macrocyclic Chelators For Labelling With 111In And 68Ga Improves Contrast Of Her2 Imaging Using Engineered Scaffold Protein Adapt6
    Garousi, J.
    Witting, E.
    Lindbo, S.
    Vorobyeva, A.
    Altai, M.
    Oroujeni, M.
    Mitran, B.
    Orlova, A.
    Hober, S.
    Tolmachev, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S131 - S131
  • [22] Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m
    Javad Garousi
    Sarah Lindbo
    Bogdan Mitran
    Jos Buijs
    Anzhelika Vorobyeva
    Anna Orlova
    Vladimir Tolmachev
    Sophia Hober
    Scientific Reports, 7
  • [23] Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m
    Garousi, Javad
    Lindbo, Sarah
    Mitran, Bogdan
    Buijs, Jos
    Vorobyeva, Anzhelika
    Orlova, Anna
    Tolmachev, Vladimir
    Hober, Sophia
    SCIENTIFIC REPORTS, 2017, 7
  • [24] Imaging agents for in vivo molecular profiling of disseminated prostate cancer: Cellular processing of [111In]-labeled CHX-A "DTPA-trastuzumab and anti-HER2 ABY-025 Affibody in prostate cancer cell lines
    Malmberg, Jennie
    Tolmachev, Vladimir
    Orlova, Anna
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (03) : 523 - 528
  • [25] Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of 68Ga-Labeled Porphyrin: Impact on Pharmacokinetics and Tumor Uptake in a Mouse Model
    Guleria, Mohini
    Das, Tapas
    Amirdhanayagam, Jeyachitra
    Sarma, Haladhar D.
    Dash, Ashutosh
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2018, 33 (01) : 8 - 16
  • [26] Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on 111In- and 125I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 Affibody
    Malmberg, Jennie
    Sandstrom, Mattias
    Wester, Kenneth
    Tolmachev, Vladimir
    Orlova, Anna
    NUCLEAR MEDICINE AND BIOLOGY, 2011, 38 (08) : 1093 - 1102